November 4, 2024 The purpose of the Cafe Scientifique was to bring together a panel of leading researchers in Canada with expertise on psychedelics and health equity. An Advisory Committee wascomprised of 13 members (see Appendix A) to provide oversight on the project, includingselecting the panelists and deciding on the format of the event. Support […]
Cafe Scientifique on Psychedelics and Health Equity: Final Report Read More »
Our SAP Tip Sheet is now live! Learn how you can access Psychedelic-Assisted Therapy (PAT) through Health Canada’s SAP program. You can find tips and templates to streamline your application process here: Navigate the PAT application process with ease through our step-by-step guidance. Prepare for success by learning about common responses and feedback from Health
Special Access Program Tip Sheet Read More »
MAPS Canada Responds to Alberta’s New Regulation for Psychedelic Drug Treatment Services Alberta’s new Regulation for Psychedelic Drug Treatment Services was implemented on January 16th. Prior to its implementation, MAPS Canada hosted a webinar in December to discuss its implications. The webinar was well-attended, with approximately 100 participants. We collected the questions posed by the presenters
MAPS Canada Responds to Alberta’s New Regulation for Psychedelic Drug Treatment Services Read More »
Neural plasticity has been the subject of much debate, and hype both in the scientific community as well as the general public. At the same time, research into the transformative potential of psychedelics has exploded. There are multiple avenues that scientists are using to understand how mind-altering substances work on the brain. One of them
Psychedelics and Neural Plasticity Read More »
Introduction Over the past several years, MDMA (also known as Ecstasy/Molly) has been making waves in the realms of drug research and therapy, with many efforts having been largely spearheaded by MAPS. Recognized for its ability to enhance feelings of empathy and bonding among users, research has largely aimed at examining MDMA’s therapeutic potential for
Objective The Center for Psychedelic and Consciousness Research at Johns Hopkins Medical school in Baltimore conducted a randomized, controlled clinical trial to examine if one or two administrations of psilocybin, in addition to psychological support, could be an effective treatment for patients suffering from major depressive disorder (MDD). What is Major Depressive disorder? Major depressive
Dear MAPS Canada Community, We are very excited to be announcing the release of our brand new MAPS Canada Podcast. This is a project that has been completely spearheaded by our volunteer Podcast Committee and has been building momentum behind the scenes since last fall. Our team has been hard at work drafting up a
Announcing the MAPS Canada Podcast Read More »
Are people of colour included in psychedelic research? In their paper “Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature” Michaels et al. (2018) reviewed studies on psychedelic-assisted psychotherapy published between 1993 and 2017 across countries to examine rates of inclusion for people of colour. Below we have summarized the key
In Kyle Shannon’s Towards Data Science’s article, “A Guide to Reading Academic Research”, Shannon emphasizes that reading scientific papers is not just for gathering the right information for a good grade or bragging rights. “Reading papers certainly builds character”, he suggests. From researcher, to child, to performance athlete, we all have experience in building character
Why Learn How to Read Scientific Papers? Read More »
The monumental year of 2020 was a lot . With all the changes that happened around the world, it is worth noting that despite the stagnation of our lives in lock-down, there was a juxtaposing movement of rapid sociopolitical developments happening outside of our homes – including the positive strides and legal wins made amidst
Psychedelics in Canada: 2020 Review Read More »
